Dr Reddy’s Laboratories has launched donepezil hydrochloride tablets, 23 mg in the US market, following the United States Food & Drug Administration's (FDA's) approval for its ANDA donepezil hydrochloride tablets, 23 mg. The donepezil hydrochloride tablet is a therapeutic equivalent generic version of ARICEPT, 23 mg.

The ARICEPT, 23 mg brand had US sales of approximately $92.6 million MAT for the most recent twelve months ending in May 2013 according to IMS Health.

Dr Reddy’s donepezil hydrochloride tablets, 23 mg is available in bottle count sizes of 30 and 90.

Dr Reddy’s Laboratories is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.